证券记录 · 已归档季度
A
Agilent Technologies, Inc. · Healthcare · Medical - Diagnostics & Research
22被追踪持有人
+2Δ持有人
109.95M持有股份
$14.10B报告持仓市值
+3新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 -0.4% ·
净新建仓位 +4.5%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 152.88K | $24.44M | n/a | −3 |
| Q2 2026 | 164 | +3 | 194.45M | $25.84B | +9 | −7 |
| Q1 2026 | 165 | -3 | 181.10M | $20.68B | +3 | −7 |
| Q4 2025 | 167 | +1 | 200.20M | $27.23B | +3 | −1 |
| Q3 2025 | 22 | +2 | 109.95M | $14.10B | +3 | −2 |
| Q2 2025 | 18 | -1 | 102.37M | $12.08B | n/a | −1 |
| Q1 2025 | 16 | -1 | 41.13M | $4.81B | n/a | −1 |
| Q4 2024 | 17 | +1 | 41.24M | $5.54B | +2 | −1 |
| Q3 2024 | 15 | -1 | 26.67M | $3.96B | +1 | −2 |
| Q2 2024 | 16 | n/a | 29.82M | $3.86B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 34.04M | +0.1% | $4.37B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 26.14M | +1.0% | $3.36B | 0.1% | ▲ Add | 2 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 12.44M | -0.1% | $1.60B | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 9.38M | +4.8% | $1.20B | 0.2% | ▲ Add | 6 | SEC ↗ ×8 |
| 5 | Geode Capital Management ✦ (被动) | 7.40M | +1.1% | $945.98M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 4.51M | n/a | $579.37M | 0.0% | n/c | 1 | SEC ↗ ×32 |
| 7 | Morgan Stanley ✦ | 4.35M | n/a | $558.28M | 0.0% | n/c | 1 | SEC ↗ ×19 |
| 8 | Goldman Sachs Group ✦ | 2.53M | n/a | $324.63M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 9 | AQR Capital Management ✦ | 1.68M | -17.7% | $209.32M | 0.1% | ▼ Trim | 6 | SEC ↗ ×6 |
| 10 | Marshall Wace ✦ | 1.59M | +5.3% | $204.32M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 1.52M | +38.7% | $195.19M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 12 | PRIMECAP Management ✦ | 1.41M | -7.7% | $181.32M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 1.12M | -7.6% | $143.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 14 | T. Rowe Price ✦ | 445.41K | -7.4% | $57.17M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | Arrowstreet Capital ✦ | 425.38K | +91.6% | $54.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 392.66K | -76.2% | $50.40M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 17 | Point72 Asset Management ✦ | 260.12K | 新增 | $33.39M | 0.1% | New | 1 | SEC ↗ |
| 18 | Adage Capital Partners ✦ | 133.59K | -27.7% | $17.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 73.72K | -83.7% | $9.46M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 47.70K | 新增 | $6.12M | 0.0% | New | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 42.80K | +256.4% | $5.49M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 1.66K | 新增 | $212,873 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $33.39M | 0.1% |
| Bridgewater Associates | $6.12M | 0.0% |
| Fisher Asset Management | $212,873 | 0.0% |
已清仓
| Norges Bank | $395.09M | 曾为 0.0% |
| D. E. Shaw & Co. | $2.43M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,065 持有人, 251.21M 股份, $26.86B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 04
Dolsten Mikael
Director · 634 股 · $95,972
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据